EXEL

Exelixis (EXEL)

About Exelixis (EXEL)

Exelixis, Inc. is an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. The company was founded by Stelios Papadopoulos on November 15, 1994, and is headquartered in Alameda, CA.

Details

Daily high

$52.95

Daily low

$50.80

Price at open

52 Week High

$53.93

52 Week Low

$33.76

Market cap

12.9B

Dividend yield

0.00%

Volume

1,556

Avg. volume

2.6M

P/E ratio

17.02

Exelixis News